European Agency Recommends Approval of Stelara to Treat Crohn’s Disease
News
The Committee for Medicinal Products for Human Use (CHMP), the scientific board of European Medicines Agency (EMA), has issued a positive opinion on Janssen’s Stelara (ustekinumab) for the treatment of patients with moderate-to-severe active ... Read more